Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

3.7%

16 terminated/withdrawn out of 432 trials

Success Rate

96.1%

+9.6% vs industry average

Late-Stage Pipeline

51%

221 trials in Phase 3/4

Results Transparency

57%

226 of 395 completed trials have results

Key Signals

4 recruiting226 with results15 terminated

Enrollment Performance

Analytics

Phase 3

144(38.0%)

Phase 2

86(22.7%)

Phase 4

77(20.3%)

Phase 1

61(16.1%)

N/A

11(2.9%)

379Total

Phase 3(144)

Phase 2(86)

Phase 4(77)

Phase 1(61)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (432)

Showing 20 of 432 trials

NCT06316297Phase 1Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Role: lead

NCT03284710Phase 1Completed

Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine

Role: collaborator

NCT06727058Phase 1Completed

Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older

Role: lead

NCT06604767Phase 1Completed

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Role: lead

NCT06736041Phase 3Active Not Recruiting

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Role: lead

NCT07536048Not Yet Recruiting

A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years

Role: lead

NCT01915212Phase 1Completed

Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

Role: collaborator

NCT06134648Phase 1Completed

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Role: lead

NCT06251024Phase 2Completed

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Role: lead

NCT06800885Completed

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

Role: lead

NCT06793826Completed

Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

Role: lead

NCT04127786Phase 3Completed

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults

Role: lead

NCT07222059Phase 3Completed

Phase 3 Single Arm, Open Study on vYF in Adults

Role: lead

NCT06705140Phase 3Terminated

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Role: lead

NCT06397768Phase 3Terminated

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Role: lead

NCT06252285Phase 3Terminated

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Role: lead

NCT05687279Phase 1Completed

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

Role: lead

NCT04486638Recruiting

Dengvaxia US Pregnancy Registry

Role: lead

NCT05794230Phase 3Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Role: lead

NCT06647407Phase 1Active Not Recruiting

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Role: lead